Form 4 for SKIN SkinHealth Systems Inc.
Accepted 2024-06-11 00:00:00 ET · period of report 2023-12-20 · accession 0001628280-24-027737 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-06-11 | 2023-12-20+ | SKIN | BECK MARLA MALCOLM | Pres, CEO, Dir | F - Tax | $3.43 | -64.2K | 1.01M | -6% | -$220.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-12-20 | F | D | 10,676 | $3.18 | 1,067,538 | D | — | — | |
| 2 | Common | Class A Common Stock | 2024-01-20 | F | D | 10,663 | $2.43 | 1,056,875 | D | — | — | |
| 3 | Common | Class A Common Stock | 2024-02-20 | F | D | 10,720 | $2.98 | 1,046,155 | D | — | — | |
| 4 | Common | Class A Common Stock | 2024-03-20 | F | D | 10,720 | $4.36 | 1,035,435 | D | — | — | |
| 5 | Common | Class A Common Stock | 2024-04-08 | F | D | 21,439 | $3.80 | 1,013,996 | D | — | — |